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Abstract 36 
The formation, composition and physical properties of lunar dust are 37 
incompletely characterised with regard to human health. While the physical and 38 
chemical determinants of dust toxicity for materials such as asbestos, quartz, volcanic 39 
ashes and urban particulate matter have been the focus of substantial research efforts, 40 
lunar dust properties, and therefore lunar dust toxicity may differ substantially. In this 41 
contribution, past and ongoing work on dust toxicity is reviewed, and major 42 
knowledge gaps that prevent an accurate assessment of lunar dust toxicity are 43 
identified. Finally, a range of studies using ground-based, low-gravity, and in situ 44 
measurements is recommended to address the identified knowledge gaps. Because 45 
none of the curated lunar samples exist in a pristine state that preserves the surface 46 
reactive chemical aspects thought to be present on the lunar surface, studies using this 47 
material carry with them considerable uncertainty in terms of fidelity. As a 48 
consequence, in situ data on lunar dust properties will be required to provide ground 49 
truth for ground-based studies quantifying the toxicity of dust exposure and the 50 
associated health risks during future manned lunar missions. 51 
1. Introduction 52 
The current renewed interest in human exploration of the Moon is driven not 53 
only by an urge to expand the human presence to other celestial bodies, but also by 54 
genuine scientific interest. Many aspects of the origin and evolution of the Earth and 55 
the other bodies in our solar system remain unclear. The Moon is thought to hold 56 
important information about the time when our own planet was formed, and humans 57 
remain capable of much more intelligent and adaptive exploration of the Moon than 58 
even the most sophisticated robotic and remote-controlled devices (e.g., Crawford et 59 
al., 2012). Identification and retrieval of representative or exotic mineral specimens, 60 
and drilling deep into the lunar subsurface are examples of tasks for which astronauts 61 
are superior to machines. The most compelling argument for human exploration is the 62 
unique ability of humans to identify and quickly assess the unexpected, enabling real-63 
time adjustment of a pre-planned exploration strategy. 64 
Although humans have landed on and returned from the Moon during the 65 
Apollo era, it is still a formidable challenge to secure the health and safety of 66 
astronauts during Moon missions. Challenges for future missions include long-term 67 
low- or microgravity, radiation exposure, and the maintenance of a number of life 68 
support systems during a much longer period than was the case during the Apollo 69 
flights (e.g., Cain, 2010, 2011). 70 
One of the biggest challenges may be related to the presence of dust on the 71 
lunar surface. The ubiquity of fine dust particles on the surface of the Moon plays an 72 
important and often dual role in many aspects of human lunar exploration. On the one 73 
hand, identifying the mineralogical and chemical composition of the dust fraction of 74 
lunar soils can provide in situ geological context for both robotic and human landing 75 
sites. In addition, lunar dust may be an ideal starting material for a range of future in 76 
situ resource utilization activities on the Moon (e.g., Taylor et al., 2005), and dust is 77 
an important component of the lunar exosphere (Horanyi and Stern, 2011). 78 
On the other hand, dust can adversely affect the performance of scientific and 79 
life-support instruments on the lunar surface. Fine dust was spread over all parts of the 80 
Apollo astronauts space suits, ending up in the habitat (Figure 1a), resulting in 81 
astronaut exposure times of several days. The Apollo astronauts reported undesirable 82 
effects affecting the skin, eyes and airways that could be related to exposure to the 83 
dust that had adhered to their space suits during their extravehicular activities, and 84 
was subsequently brought into their spacecraft (Figure 1b). 85 
Dust exposure and inhalation could have a range of toxic effects on human 86 
lunar explorers, especially if longer exposure times become the norm during future 87 
manned exploration missions. There is therefore a need to assess the risks to health. 88 
The physical and chemical determinants of dust toxicity for terrestrial materials such 89 
as asbestos, quartz, volcanic ashes and urban particulate matter have been studied in 90 
great detail, and lunar dust simulant (synthesised from terrestrial volcanic material) 91 
has been found to exhibit toxic effects (Lam et al., 2002; Latch et al., 2008; Loftus et 92 
al., 2010). Unique features of actual lunar dust (described in more detail in section 3), 93 
resulting from its formation by (micro)meteoroid impacts and its extended radiation 94 
exposure in the absence of oxygen and humidity, could lead to toxic effects 95 
significantly exceeding those of simulants made from Earth materials. At present, the 96 
formation, composition and physical properties of lunar dust remain incompletely 97 
characterised with regard to human health. 98 
In a micro-/hypo-gravity environment the risk of inhalation of dust is 99 
increased due to reduced gravity-induced sedimentation. Inhaled particles tend to 100 
deposit more peripherally and thus may be retained in the lungs for longer periods in 101 
reduced gravity as will be the case in a future lunar habitat (Darquenne and Prisk, 102 
2008; Peterson et al., 2008). Inhalation of particles of varying size may affect the 103 
respiratory and cardiovascular systems in deleterious ways leading to airway 104 
inflammation and increased respiratory and cardiovascular morbidity (Frampton et al., 105 
2006; Sundblad et al., 2002).  106 
In this contribution, we review our knowledge of the physical chemistry 107 
determinants of dust toxicity, of the composition and size of lunar dust, and all aspects 108 
related to its toxicity. We identify a number of knowledge gaps that need to be filled 109 
to constrain the required extent of mitigation activities protecting astronauts from the 110 
potentially toxic effects of lunar dust during and after a stay on the Moon. We also 111 
recommend a range of future studies using ground-based, low-gravity, and in situ 112 
measurements on the lunar surface to better constrain lunar dust toxicity.  113 
 114 
2. Physical chemistry determinants of dust toxicity 115 
2.1. What makes a dust particle toxic? 116 
Up to the 1980s, fibrous character of asbestos (e.g., Kane, 1996; Mossman et 117 
al., 1990; Stanton et al., 1981), crystallinity of silica (e.g., Castranova et al., 1996; 118 
1997; 2011), and degree of graphitization of carbon (e.g., IARC 1997; 2010) were 119 
considered the main physico-chemical determinants of the pathogenicity of these 120 
well-recognized particulate toxicants. Starting in the early 1990s, free radical release 121 
has been progressively accepted as a relevant additional factor in causing cell and 122 
tissue damage and DNA modifications (Fubini and Hubbard, 2003; Kamp and 123 
Weitzman, 1999; Sanchez et al., 2009; Shukla et al., 2003). The triggering or catalysis 124 
of these atomic-scale mechanisms by active sites located at the surface of the particles 125 
was subsequently elucidated (Fubini and Fenoglio, 2007; Fubini and Otero-Arean, 126 
1999; Pezerat et al., 2007). Several additional aspects of surface chemistry and 127 
reactivity, including hydrophilicity / hydrophobicity and contamination by metals, are 128 
now also considered to play a role in particle toxicology. 129 
With the advent of nanotechnology, there was an abrupt rise of interest in 130 
particle toxicology, because of the general fear that particles would exhibit an 131 
increased and/or new form of toxicity when nano-sized. Once again attention was 132 
directed to surface properties (e.g. extent and reactivity) as most of the adverse 133 
reactions caused by nanoparticles appear to take place at what has been designated as 134 
the “bionanointerface” (Fubini et al., 2011; Nel et al., 2009; Nel et al., 2006). 135 
 When toxicants act in particulate form, the mechanisms of toxicity are much 136 
more complex when compared to molecular toxicants, for the following main reasons: 137 
• It is the surface of a particle which is in contact with fluids, cells and tissues. 138 
• The same particle may act in multiple stages of the pathogenic process. 139 
• The particle may stay in vivo for long periods of time, moving throughout the 140 
body.   141 
• The particle may be modified in vivo. 142 
The toxic potential of a particle is determined by several features rather than 143 
one specific property. It is generally accepted that three main factors contribute to the 144 
toxic potential of a given particulate: form, surface reactivity and biopersistence 145 
(Fubini and Otero-Arean, 1999). Form accounts for the fibrous character, nano-size, 146 
and complexity of particle morphology. Surface reactivity comprises all possible 147 
chemical reactions at the particle–living matter interface, which are determined or 148 
modulated by chemical composition, crystal structure, surface roughness (abraded 149 
versus smooth), origin (i.e. the way the material was prepared or reduced in 150 
particulate size) or contamination in the environment, e.g. by trace metals. Metal 151 
contamination may also occur in vivo, if the particle surface has potential to 152 
accommodate metal ions at surface charges or defects (Hardy and Aust, 1995a; Turci 153 
et al., 2011). Biopersistence is a term used to indicate the potential of a particle to 154 
remain substantially unaltered within a given biological compartment. It is related to 155 
dissolution in body fluids, but also to the efficiency of the methods of clearance, 156 
which both depend upon the shape of the particle, chemical composition and extent of 157 
the surface exposed. The longer a particle remains in a critical biological compartment 158 
causing stress to cells and tissues, the greater the risk of any adverse effect. 159 
 160 
2.2. Fate of a particle in the body following inhalation 161 
 A schematic view of the generally accepted mechanisms of toxicity of inhaled 162 
particles is presented in Figure 2. Note that the inflammatory reaction described here 163 
may occur via other penetration routes (e.g. skin, systemic circulation). Before 164 
interacting with cells, particles will adsorb molecules (mainly proteins) from the 165 
surrounding fluids, resulting in partial or full coating (Turci et al., 2010). This process 166 
depends upon both the particle surface properties and protein characteristics (Lynch 167 
and Dawson, 2008; Nel et al., 2009; Norde, 2008).  168 
 Naturally occurring antioxidants in the lung-lining fluids may react and be 169 
consumed at the particle surface (Figure 2, step 1) (Brown et al., 2000; Fenoglio et al., 170 
2003; Fenoglio et al., 2000). Soon the immune system will engulf the foreign body by 171 
recruited alveolar macrophages (AMs) to clear the particle out of the lung (step 2). 172 
Depending upon the surface characteristics of the particle itself this clearance process 173 
may succeed (step 3) or fail (step 4). In the latter case, macrophages will become 174 
activated at the cellular and molecular level with activation of transcription factors 175 
and release of reactive oxygen or nitrogen species, chemotactic factors, lytic enzymes, 176 
cytokines, and growth factors (Fubini and Hubbard, 2003; Shukla et al., 2003; van 177 
Eeden et al., 2001). Eventually macrophages die (necrosis / apoptosis) and the particle 178 
is released at the lung surface again. Subsequent ingestion-re-ingestion cycles, 179 
accompanied by a continuous recruitment of alveolar macrophages, 180 
polymorphonuclear cells and lymphocytes, can cause sustained and chronic 181 
inflammation, which may evolve into several diseases, including cancer. Target cells 182 
such as bronchiolar and alveolar epithelial cells will then be affected by both alveolar 183 
macrophage products (step 5) and by direct interaction (step 6) with the extracellular 184 
particle itself (Fubini et al., 2010). Inhaled nanoparticles (NPs) partly escape alveolar 185 
macrophage surveillance following deposition in the alveolar regions of the lung, and 186 
may in some cases migrate to the pulmonary interstices or the systemic circulation 187 
(step 7) (Nel et al., 2009; Warheit et al., 2008), as discussed further in section 5.   188 
 189 
2.3. Physical-chemical factors related to toxicity  190 
Free radical generation is the most strongly implicated feature in the 191 
mechanisms of toxicity. Free radicals, reactive oxygen species and transition metal 192 
ions act at stages 1, 3, 5 and 6 in Figure 2. Particle-derived free radicals associated to 193 
cell-derived reactive oxygen species and reactive nitrogen species cause oxidative 194 
stress in surrounding cells, which is exacerbated if the antioxidant defences are 195 
consumed (as shown schematically in Figure 3). When in contact with biological 196 
fluids, many dusts generate free radicals via various mechanisms, including reduction 197 
of oxygen, OH. from hydrogen peroxide (Fenton mechanism) and homolytic rupture 198 
of carbon-hydrogen bonds (Fubini et al., 2010; Fubini and Hubbard, 2003). 199 
Several surface states (i.e. surface sites which may exchange electrons) are 200 
associated with these reactions including “dangling bonds” (unsatisfied valences), 201 
poorly coordinated transition metal ions (typically iron or titanium), defects, and 202 
electron donating centres. Other surface properties relevant to toxicity are: 203 
(1) Surface charge and H-bonding potential. These are the main determinants 204 
for phospholipid and protein adsorption, which in turn is implicated in cell adhesion 205 
and membrane activation or rupture (Nel et al., 2009; Nel et al., 2006). 206 
(2) Degree of hydrophilicity/hydrophobicity, which determines the event 207 
following cell-particle interaction and clearance. Hydrophilicity originates in polar 208 
chemical functionalities (e.g. SiOH) or under-coordinated metal ions at the surface. 209 
For example, fully heat-hydrophobized cristobalite has been shown to lose its toxic 210 
potential towards several cell types (Fubini et al., 1999). The main roles of this 211 
property in the interaction of cell membranes with metal oxides have been described 212 
(Sahai, 2002). In the case of nanoparticles, hydrophobicity favours clumping and 213 
aggregation in aqueous media (carbon nanotubes are a typical example), whereas 214 
hydrophilic nanoparticles, aggregated in air, behave in a complex way in body fluids 215 
depending upon size and shape (Parsegian, 2006). 216 
(3) Dispersion of metal ions. In addition to forming catalytic centres for free 217 
radical generation, well-dispersed metal ions may also be released in body fluids and 218 
tissues (Castranova et al., 1997; Hardy and Aust, 1995b). 219 
(4) Material association. Association of different materials may result in new 220 
toxic entities, as shown for Indium Tin Oxide [ITO] (Lison et al., 2009) and for the 221 
combination of cobalt and tungsten carbide (Lison et al., 1995). In such cases, while 222 
the individual components are not, or only modestly toxic, their association generates 223 
a very toxic material. For example, cobalt + tungsten carbide particles are the cause of 224 
“Hard Metal Lung Disease” (Lison et al., 1995). 225 
In the next section, we describe the composition and properties of lunar dust in 226 
light of the physico-chemical determinants discussed in this section, and assess their 227 
relevance to the potential toxicity of lunar dust.   228 
 229 
3. Composition and size distribution of lunar dust 230 
3.1. Characteristics of the lunar surface 231 
The surface of the Moon is covered by regolith. Regolith consists mainly of a 232 
wide range of crystalline and amorphous fragments produced by meteoroid impacts; 233 
glassy and partially crystallised spheres of volcanic origin, and agglutinates. 234 
Agglutinates is a term used for rock and mineral fragments welded together by glassy 235 
material formed upon impact of meteoroids (Lucey et al., 2006). Lunar soil generally 236 
refers to the size fraction of the regolith smaller than 1 cm in diameter (coinciding 237 
with the coarsest mesh size used to sieve Apollo samples upon return to Earth). The 238 
mean grain size of lunar soil varies between 40 and 800 µm, with an average at 239 
approximately 70 µm (Lucey et al., 2006). The term lunar dust is used for the fraction 240 
of lunar soil with a diameter smaller than 20 µm (McKay et al., 1991). For soil 241 
samples brought back to Earth during the Apollo missions, the proportion of dust in 242 
any soil is approximately 20 weight per cent [wt%] (Basu et al., 2001; Graf, 1993). 243 
Dust formation mechanisms, and more extensive overviews of dust properties, are 244 
provided in a recent review by Liu and Taylor (2011).   245 
 246 
3.2. Lunar dust and dust simulant properties 247 
 Taylor and colleagues provided the most extensive studies to date of the 248 
mineralogical composition of two lunar dust fractions (sizes between 20 and 10 µm, 249 
and smaller than 10 µm, respectively) for nineteen different Apollo soils (Taylor et 250 
al., 2001a; Taylor et al., 2001b; Taylor et al., 2010). The samples were taken from 251 
both mare and highland areas of the lunar surface. Based on automated point-counting 252 
of > 150,000 areas in each sample, they conclude that > 70 % of dust consists of 253 
pyroxene, plagioclase, and impact glass-rich particles. The relative proportions of 254 
each phase vary as a function of bedrock type (mare versus highland), size fraction 255 
and soil maturity (a measure of the exposure age of the surface, with more mature 256 
soils having been exposed for longer periods of time). The more mature and smaller 257 
size fractions contain larger proportions of impact glass. Minor components of the 258 
dust include the minerals olivine and ilmenite as well as glass spherules formed in 259 
fire-fountaining volcanic eruptions on the lunar surface. A key observation, which 260 
may be important for lunar dust toxicity, is the presence of nanophase iron [np-Fe] in 261 
glassy rims of dust particles. This phase is formed during vapour deposition caused by 262 
flash heating of mineral or glass phases due to (micro)meteoroid impacts. The 263 
proportion of nanophase iron also appears to increase with decreasing dust grain size. 264 
 Based on the trends observed in the size fractions, Taylor and colleagues 265 
suggest that the respirable size fraction (typically considered to be < 5 μm) of lunar 266 
dust is likely dominated by impact glass and rich in metallic iron (Taylor et al., 2010). 267 
A recent study by Thompson and Christoffersen (2010) confirmed that approximately 268 
80 % of submicron dust particles consists of glass. However, the proportion of np-Fe 269 
found was lower than predicted by Taylor and co-workers. This difference illustrates 270 
the first key issue with lunar dust studies in light of its possible toxicity: A 271 
comprehensive study of the properties and compositions of the very small size 272 
fraction of lunar dust (e.g., particles < 1 µm) is missing. Such a study will be required 273 
to bridge the current gap between size fractions relevant to toxicity studies and the 274 
currently state-of-the-art work by Taylor and co-workers, that groups all particles < 275 
10 µm as the smallest fraction. Finally, we note that the Apollo samples studied to 276 
date are of near-equatorial origin and their mineralogy and physical properties may 277 
not be representative of other areas on the lunar surface including the South Polar 278 
region and the floor of the South Pole – Aitken basin, where future landing sites are 279 
proposed. 280 
 NASA developed several lunar soil analogues to minimize use of real lunar 281 
materials in mechanical engineering and in situ resource utilization studies. Lunar soil 282 
simulants JSC-1 (McKay et al., 1994) and JSC-1A (Hill et al., 2007) were produced 283 
from a Arizona volcanic tuff and ash deposit. JSC-1 is no longer available, and JSC-284 
1A is commonly used as the lunar soil simulant. The mechanical properties of JSC-1A 285 
are close to those of real lunar soil. The simulant contains a large proportion 286 
(approximately 50 wt%) of volcanic glass, and its bulk chemical composition is 287 
similar to that of some of the Apollo 14 soils (Hill et al., 2007), which consist mainly 288 
of impact ejecta (which is not pure mare nor pure highland material). There are some 289 
key differences between JSC-1A and lunar soil. The glass in JSC-1A is not 290 
agglutanitic (was not formed due to flash heating during impacts) and is therefore not 291 
as friable. JSC-1A does not contain any ilmenite (a potentially toxic iron-titanium 292 
oxide that is present in all lunar soils); and it contains no nanophase iron. Instead, due 293 
to the presence of trivalent iron, nanoparticles of Ti-bearing magnetite are found in 294 
JSC-1A. These have magnetic properties mimicking those of nanophase iron (Hill et 295 
al., 2007; Liu and Taylor, 2011). Finally, JSC-1A contains approximately 0.7 wt% 296 
water incorporated mainly into clay minerals (McKay et al., 1994), whereas bulk 297 
lunar soil is virtually dry. 298 
 One lunar dust simulant of particular importance to lunar dust toxicity studies 299 
is JSC-1Avf, a < 20 μm sieved “very fine” fraction of JSC-1A. As far as we are 300 
aware, its mineralogical and chemical composition has not been studied in detail, but 301 
is assumed to be similar to that of JSC-1A (Hill et al., 2007).  302 
 Particle size is a key factor in toxicity studies because it defines transport 303 
pathways into the lung. Size reduction may also lead to an increase in surface 304 
reactivity (Fubini et al., 2010). Determining the size distributions of lunar dust 305 
particles was not a primary science objective at the time of Apollo and this important 306 
aspect for dust retention in the lungs should be reassessed. A summary of cumulative 307 
particle size distribution (PSD) measurements of lunar soils is given in Figure 4a, 308 
showing variations in the proportion of dust in Apollo soils between less than 10 wt% 309 
and greater than 30 wt%. Figure 4a illustrates a second knowledge gap regarding the 310 
toxicity of lunar dust: Classic PSD measurements did not consider particles smaller 311 
than 1 µm, and therefore ‘miss’ a portion of the respirable dust fraction. Careful 312 
analysis of the size distribution of the dust fraction of Apollo soils including the very 313 
fine fraction (Figure 4b) show log-normal number distributions with peaks in the 0.1 – 314 
0.2 μm range (Park et al., 2008). This contrasts with analyses of JSC-1Avf, which 315 
peaks at approximately 0.7 μm. Finally, we note that although surface shape and 316 
surface area are key aspects in dust toxicity research, the surface morphology of lunar 317 
dust grains is at present poorly characterised (e.g. (Liu et al., 2008)). Electron 318 
microscope images of lunar dust show that many grains are highly vesicular 319 
suggesting a very high surface area, but quantitative data are currently absent.  320 
 321 
3.3. The potential toxicity of lunar dust 322 
Lunar dust appears to have many of the characteristics of particulate matter 323 
that cause adverse health effects (section 2). Hurowitz and colleagues observed that 324 
freshly fractured lunar regolith is able to produce large amounts of highly reactive 325 
oxygen species (Hurowitz et al., 2007) which are known to induce inflammation and 326 
adverse effects on cellular metabolism. Some peculiarities of lunar dust might trigger 327 
new toxicity paths and exacerbate the classical inhaled particle effects of terrestrial 328 
dusts. The surfaces exposed will all be generated by mechanical rupture of rocks and 329 
minerals, which causes a much higher surface reactivity (Damm and Peukert, 2009; 330 
Fenoglio et al., 2001) hence toxicity (Vallyathan et al., 1988) compared to unfractured 331 
material. Lunar dust particles will be rich in dangling bonds and unsatisfied valencies 332 
because of mechanical impacts and abrasion of bedrock and regolith (Figure 5). 333 
Furthermore on the Moon dangling bonds and charges will be more abundant and 334 
persist for much longer periods of time in the absence of oxygen or liquid water, 335 
which both assist defect healing and surface reconstruction (Wallace et al., 2010). 336 
Vitreous materials, which are abundant on the lunar surface, have seldom been 337 
studied in terms of their toxicity. Their reactivity - hence toxicity - might be different 338 
from either their crystalline counterparts or other amorphous forms not obtained in 339 
particulate form by mechanical stress, but by e.g. sedimentation. This could have a 340 
large effect on toxicity, analogous to the observed toxicity contrast between vitreous 341 
and precipitated amorphous silicas (Ghiazza et al., 2010). Continuous exposure to 342 
radiation and solar winds will enrich the particles in reactive sites and electron 343 
donating centers. Photoactivation, similar to what takes place with titanium dioxide 344 
(Fenoglio et al., 2009; Fujishima et al., 2008), might also occur inducing the release of 345 
reactive oxygen species responsible for oxidative damage. This extremely large 346 
concentration of surface charges, unsatisfied valencies and reactive sites is expected 347 
to readily react when particles are immersed in any body fluid (Loftus et al., 2010; 348 
Wallace et al., 2010). All these features of lunar dust are consistent with the reports 349 
from Apollo astronauts on the extreme stickiness on all surfaces of the dust (e.g., 350 
NASA Manned Spacecraft Center, 1973). 351 
As to the degree of hydrophilicity / hydrophobicity, it seems that fully 352 
hydrophobic (Fubini et al., 1999) and fully hydrophilic (Gazzano et al., submitted) 353 
silicas appear much less cytotoxic than specimens with mixtures of hydrophilic and 354 
hydrophobic sites. Lunar dust cannot be expected to show the same level of 355 
hydrophilicity as terrestrial dust due to the differences in hydrogen/water abundance 356 
between the Earth and the Moon. However, some surface active sites may readily 357 
react upon contact with water in the body. Under these circumstances, hydrophilic 358 
sites will appear at the particle surface but full hydroxylation will not been attained 359 
unless extremely long periods of time are available. 360 
Nanophase iron particles are also an expected source of toxicity because of 361 
their size and the complex redox chemistry taking place at their surface when exposed 362 
to air. Such nanoparticles have been reported to be embedded into a vitreous matrix in 363 
lunar dust grain rims (Wallace et al., 2010). It is therefore unknown if direct 364 
interactions between the nanophase iron and the body will occur. Taking into account 365 
the long clearance times expected (which may allow partial dissolution of the 366 
amorphous silicate) and the persistent particle disruption taking place at the lunar 367 
surface, it seems likely that the iron surface might come in direct contact with cells 368 
and tissues. The toxicity of ilmenite - an iron titanium oxide - has never been 369 
considered and because of the presence of iron as well as titanium it might have 370 
adverse effects if inhaled. 371 
These iron-containing materials could react with hydrogen peroxide to 372 
undergo a surface-induced Fenton-like reaction, ultimately producing reactive free 373 
radicals. Some similarities may be found between terrestrial volcanic ashes and lunar 374 
dust. In terrestrial ashes, iron is always only partially oxidised to trivalent iron. This 375 
appears to be one of the causes of sustained free radical generation, hence potential 376 
toxicity (Horwell et al., 2007; Horwell et al., 2010). Similarly, even after exposure to 377 
air lunar dust will keep a large fraction of its iron in a low oxidation state. 378 
 379 
4. Transport of dust in the airways 380 
4.1. Basic mechanisms of particle deposition 381 
The transport of inhaled particles in the airways is generally considered to be 382 
governed by three principal transport mechanisms: inertial impaction which primarily 383 
affects particles in a size range > ~5 μm; sedimentation which dominates the size 384 
range ~0.5 to 8 μm; and diffusion for particles smaller than ~0.5 μm (West, 2001). Of 385 
these, sedimentation is a gravity-driven process and so is altered in the lunar 386 
environment where acceleration due to gravity is only ~1/6 that on the Earth’s 387 
surface.   388 
As a consequence of these different transport mechanisms, the location in the 389 
bronchial tree where particles deposit also varies, and as a result, so does the time it 390 
takes to subsequently remove the deposited particles from the lung. Both the site of 391 
deposition, and the time for removal have the potential to affect the magnitude of the 392 
toxic effect of a given particle load delivered to the lungs, and so the changes in 393 
deposition in reduced gravity may alter the toxicological potential of an airborne dust. 394 
Thus large particles deposit primarily in the naso-pharangeal region (the nose and 395 
back of the throat) and do not reach the lungs. The medium-sized particles are 396 
generally considered to deposit in the small airways. Particles smaller than 100 nm in 397 
diameter deposit primarily in the alveolar region of the lung, with the exception of the 398 
very smallest particles (smaller than ~5-10 nm) which are primarily deposited in the 399 
nose (Geiser and Kreyling, 2010).   400 
The importance of particle size in determining the health effects of dust 401 
exposure has long been appreciated. The U.S. Environmental Protection Agency 402 
(EPA) has more stringent regulations for particles smaller than 2.5 μm (termed PM2.5, 403 
with a 24-hour exposure limit of 35 μg/m3) compared to particles smaller than 10 μm 404 
(termed PM10, a 24 hour exposure limit of 150 μg/m3) 405 
(http://www.epa.gov/ttn/naaqs/standards/pm/s_pm_index.html). Early regulations 406 
controlled only total suspended particles (TSP), however this was replaced with a 407 
standard for PM10 in 1987, and subsequently augmented with a standard for PM2.5 in 408 
1997, which was then revised downwards in 2006. Such changes reflect recognition 409 
of the importance of the smaller size fractions in impacting human health.   410 
 411 
4.2. Deposition in reduced gravity  412 
Total deposition (the overall fraction of the inhaled particle load that deposits 413 
in the lung) and how that is altered by changes in the gravity level was studied in the 414 
1990s in parabolic flight. While parabolic flight only provides short periods of 415 
reduced gravity (~25 seconds of microgravity), this is sufficient time for such studies.  416 
Parabolic flight also brings with it the advantage that the surrounding periods of 417 
hypergravity can also be utilized to extend the gravity range of the studies. These 418 
studies showed an expected reduction in deposition in reduced gravity; however, 419 
when the results were compared to predictions of deposition from existing models of 420 
aerosol transport in the lung, the observed deposition of particles of ~1 μm in size was 421 
considerably higher than expected in microgravity (Figure 6) (Darquenne et al., 422 
1997). The implication drawn from these studies was that alveolar deposition of the 423 
smaller sized particles (0.5 and 1.0 μm) was higher than expected because of the 424 
combined effects of a higher alveolar concentration of particles in microgravity due to 425 
the absence of removal in the small airways by sedimentation, and the non-426 
reversibility of the flow patterns in the complicated airway geometry.   427 
The issue of non-reversible flow patterns in the lung leading to enhanced 428 
mixing between the inspired and resident gas is important in the context of aerosol 429 
deposition. While inspired gases rapidly and effectively mix with resident air through 430 
the process of molecular diffusion in the small acinar spaces of the lung, particles 431 
(even those small enough to have a significant diffusive transport component) mix 432 
much more slowly. Thus convective flow mixing is a potentially important 433 
mechanism by which particles transfer from the inspired air to resident air (and thus 434 
deposit). The higher than expected deposition of small particles seen in microgravity 435 
(Darquenne et al., 1997) implies that this transfer is more important than previously 436 
thought. It had long been assumed that because of the very low Reynolds number in 437 
the lung periphery, acinar flow was kinetically reversible. However, that concept is at 438 
odds with experimental data that show appreciable aerosol mixing at the alveolar level 439 
(Heyder et al., 1988) which occurs even in the absence of gravitational sedimentation 440 
(Darquenne et al., 1998, 1999). 441 
A likely mechanism is the complex folding of streamlines that occurs in the 442 
bifurcating geometry of the airways. This chaotic mixing, termed “stretch and fold” 443 
because of its similarity to the repeated stretching and folding of a sheet of pastry, 444 
occurs due to the rapid stretching of flow streamlines that takes place as the 445 
cumulative airway cross-sectional area increases towards the lung periphery, and due 446 
to the slight asynchrony in the expansion and contraction of adjacent lung units 447 
(Butler and Tsuda, 1998; Tsuda et al., 2002). The effect is to bring streamlines into 448 
close apposition with each other such that diffusive transport of particles between 449 
inspired and resident air, that would otherwise be ineffective, now becomes an 450 
effective transport mechanism. Studies of aerosol mixing in microgravity 451 
incorporating small flow reversals have been performed in humans (Darquenne and 452 
Prisk, 2004), and observations of complex mixing patterns in rat lungs even after only 453 
one breath have been made (Tsuda et al., 2002). Together, these studies suggest that 454 
the higher than anticipated levels of both deposition and dispersion (a measure of 455 
transfer of inhaled particles to the resident air) seen in microgravity (Darquenne et al., 456 
1998, 1999) result from the mechanism of stretch and fold.   457 
 458 
4.3. Site of deposition 459 
The location of particle deposition in the airways has important implications 460 
for their potential toxic effects. The lungs are challenged by dusts on a continuous 461 
basis and as such particle deposition is an ever-present effect. The lung deals with this 462 
through clearance mechanisms. The medium and large-sized airway epithelium is 463 
covered in a layer of cilia, which serves to move a mucus layer in the direction of the 464 
glottis where it is swallowed. Particles that deposit on the mucus layer are transported 465 
by it and thus eliminated. This mucociliary clearance system is quite effective with 466 
clearance times in the order of hours and typically less than 24 hours for particles 467 
depositing in the central airways (Scheuch et al., 1996; Smaldone et al., 1988; 468 
Stahlhofen and et al., 1989). Hence, the mucociliary clearance system serves to reduce 469 
the time a potentially toxic particle can effect the underlying tissues (Fanizza et al., 470 
2007). 471 
In contrast, particles that reach the alveolar region of the lungs are removed by 472 
the alveolar macrophages, which engulf the particles (phagocytosis) and eventually 473 
transport them to the mucociliary clearance system for removal (Figure 2). However 474 
this process is much slower. A study in humans using magnetically-labelled particles 475 
showed that while approximately half the particles were removed from the lung with a 476 
mean residence time of 3.0 ± 1.6 hours, the remaining half of the particle burden had a 477 
mean residence time of 109 ± 78 days (Moller et al., 2004), greatly increasing the 478 
potential for toxic effects. In addition, Oberdörster and co-workers showed that nano-479 
sized particles can escape macrophage surveillance, leading to even longer residence 480 
times than observed for micron-sized particles (Oberdörster et al., 2005b). 481 
To date there are no published reports of human studies that provide specific 482 
information on how the site of deposition of inhaled particles is affected by altered 483 
gravity. However indirect measurements strongly point to a more peripheral site of 484 
deposition in low gravity, consistent with the concept of the reduction in 485 
sedimentation permitting higher particle concentrations reaching the alveolar region, 486 
where other mechanisms of deposition (diffusion, complex mixing) dominate. The 487 
only published study of aerosol transport in lunar gravity (Darquenne and Prisk, 2008) 488 
showed that while lunar gravity reduced overall deposition, for a given deposition 489 
fraction deposition occurred much more peripherally than in 1 G (Figure 7). The same 490 
study also showed that the unexpectedly high deposition of small particles (0.5 and 491 
1.0 μm) seen in microgravity was still present in a lunar-gravity environment. The 492 
latter point is important in that it suggests that the results from previous studies 493 
performed in microgravity can be extrapolated to low-gravity, and that the 494 
mechanisms responsible for the higher than anticipated deposition are still operative 495 
in the presence of gravity. Recent studies have begun to measure the rate of clearance 496 
of particles deposited in humans in microgravity and compare that to the rate of 497 
clearance when the deposition occurs in 1 G (Prisk et al., unpublished observations). 498 
At present no results are available, but the expectation is that clearance will be slower 499 
as a result of the more peripheral deposition in microgravity. 500 
There are now recent data on the changes in the site of deposition in rat lungs 501 
when gravity is altered. Rats were exposed to 0.9 μm particles containing ferric oxide 502 
in either 1 G or in microgravity during parabolic flight. The lungs were subsequently 503 
excised and imaged using MRI. When the particle exposure occurred in microgravity, 504 
the ratio of deposition in the central lung regions compared to the peripheral lung 505 
regions was greatly reduced (0.58 ± 0.20 in microgravity; 1.06 ± 0.08 in 1 G; P < 506 
0.05) showing that particles deposited more peripherally in microgravity (Darquenne 507 
et al, unpublished observations).   508 
 509 
5. Non-pulmonary effects 510 
5.1. Cardiovascular effects 511 
The cardiovascular system is directly linked to the pulmonary system at the 512 
blood-air interface in the lungs. Not only are gases able to cross this interface, but dust 513 
particles smaller than 100 nm are thought to cross from the alveolar surface into the 514 
pulmonary capillaries (Nemmar et al., 2002). Nanoparticles have been found in the 515 
lymph nodes (Brain et al., 1994; Harmsen et al., 1985), spleen (Semmler et al., 2004), 516 
heart (Semmler et al., 2004), liver (Oberdörster et al., 2000; Peters et al., 2006) and 517 
even the bladder (Nemmar et al., 2002) and brain (Oberdörster et al., 2004). 518 
Experimental evidence indicates that in exposed rats some nanoparticles reached the 519 
brain, overcoming the blood brain barrier possibly through the olfactory nerve 520 
(Oberdörster et al., 2004). These observations raise the question: What are the health 521 
effects of inhaled particles on the cardiovascular system and the organs where the 522 
particles accumulate? 523 
Epidemiological studies present robust links between exposure to inhaled 524 
dusts and cardiopulmonary mortality (Dockery et al., 1993; Samet et al., 2000) but 525 
these links are the strongest for individuals with advanced atherosclerotic disease such 526 
as those with a previous heart attack (von Klot et al., 2005) or stroke (Zanobetti and 527 
Schwartz, 2001). Following an elevation of ambient air pollution, there are increased 528 
reports of strokes (Hong et al., 2002; Schwartz, 1994), heart failure exacerbations 529 
(Pope et al., 2004), cardiac arrhythmias (Peters et al., 2000), heart attacks (Peters et 530 
al., 2004; Pope et al., 2004), and sudden deaths (Schwartz, 1994).  531 
Research findings support two mechanisms that are hypothesized to be 532 
involved in the pathological response of the cardiovascular system to air pollution 533 
exposure. These mechanisms are inflammation and dysfunction of the autonomic 534 
nervous system. The inflammatory mechanism is the concept that particulate material 535 
irritates the lungs which results in first a local and then a systemic inflammatory 536 
response (Seaton et al., 1995; Seaton et al., 1999). Low grade, chronic inflammation is 537 
believed to exacerbate cardiovascular disease (Tranfield et al., 2010). The dysfunction 538 
of the autonomic nervous system manifests as irregularities in heart rate, heart rhythm 539 
and blood pressure (Peters et al., 2000; Pope et al., 1999).  540 
Extrapolating the cardiovascular effects of inhaled terrestrial dusts to the 541 
possible cardiovascular effects of lunar dust on astronauts is fraught with uncertainty 542 
because of several critical gaps in the scientific understanding of this topic. To begin, 543 
astronauts currently go through an extensive screening process for the purpose of 544 
selecting only very healthy individuals. Epidemiologically, the primary correlation 545 
between elevated air pollution levels and adverse cardiovascular events is in 546 
individuals with known cardiovascular disease (Dockery et al., 1993; Samet et al., 547 
2000). To date little research has focused on the health effects experienced by healthy 548 
individuals exposed to air pollution. Virtually all research has focused on very young 549 
populations, as well as aging, already ill populations, and astronauts do not fit in 550 
either of these categories. Secondly, lunar dust is very different compared to terrestrial 551 
dust in terms of chemical composition, method of formation, and exposure to 552 
weathering effects and solar irradiation (Horanyi and Stern, 2011; Liu and Taylor, 553 
2011). Furthermore, the site of fine dust deposition in the lungs is more peripheral 554 
(Darquenne and Prisk, 2008) and timely removal from the lungs is hypothesised to be 555 
reduced in microgravity and most probably in lunar gravity. These variables may have 556 
a greater effect on lung toxicity caused by lunar dust than cardiovascular toxicity; 557 
however, this is an area that needs to be investigated further before any scientifically 558 
sound conclusion can be drawn about how lunar dust will impact astronauts during 559 
their time on the lunar surface, and when they return to Earth.   560 
 561 
5.2. Ocular and skin effects 562 
Concern about the health effects of lunar dust is dominated by pulmonary 563 
considerations, but many lunar operational scenarios have the potential to result in eye 564 
exposure and skin exposure to lunar dust (and coarser lunar regolith) (Khan-565 
Mayberry, 2007). For eye exposure, at least two scenarios are envisioned: deposition 566 
of airborne particles onto the surface of the eye, and transfer of particles from 567 
contaminated objects, such as fingers, that may touch the eye. Exposure of the skin to 568 
lunar dust could certainly occur as a result of airborne particles, but operations that 569 
involve handling an EVA (extravehicular activity) suit that has been contaminated on 570 
the outside with lunar dust, such as EVA suit cleaning and suit repair procedures, 571 
likely represent an even greater risk of exposure. Skin exposure to lunar dust may also 572 
be of concern if the interior of the EVA suit becomes contaminated with lunar dust 573 
(e.g., by donning a suit using contaminated hands), in which case dermal abrasion 574 
may take place at sites where the suit rubs against the skin (James and Khan-575 
Mayberry, 2009). The abrasive properties of lunar dust have been documented in a 576 
variety of settings (Gaier et al., 2009; Kobrick et al., 2010). Indeed, dermal abrasion 577 
due to lunar dust may act in combination with skin damage induced by pressure on the 578 
skin at sites of anatomical prominence (finger tips, knuckles, elbows, knees), and may 579 
result in breakdown of the stratum corneum, the outermost layer of the skin which 580 
functions as the protective barrier of the skin (James and Khan-Mayberry, 2009; Jones 581 
et al., 2007).  582 
To address the concern about potential lunar dust effects in the eye, NASA’s 583 
LADTAG (Lunar Airborne Dust Toxicity Assessment Group) will be sponsoring a 584 
study that will be performed with authentic lunar dust from Apollo 14, and will be 585 
carried out in two stages. The first stage will consist of an in vitro study, using a 586 
commercially available testing system that uses differentiated keratinocytes that 587 
mimic the architecture of the cornea. To complement the in vitro study, Apollo 14 588 
lunar specimens will be tested for eye irritancy using rabbits, to assess possible 589 
corneal effects, conjunctival effects, and effects on the iris (Khan-Mayberry, 2007). 590 
Examination of lunar dust dermal effects will focus on the risk of skin abrasion. 591 
Experiments using authentic Apollo soil specimens and a pig skin abrasion model are 592 
currently underway. The ocular studies and dermal studies are expected to reveal 593 
information about the biological effects of lunar dust that is complementary to studies 594 
of lunar dust pulmonary effects and is operationally relevant for human exploration of 595 
the Moon (James and Khan-Mayberry, 2009; Khan-Mayberry, 2007).  596 
 597 
6. Dust inhalation in animal models 598 
Toxicity testing with particulate air pollutants has been performed extensively 599 
both for acute toxicity outcomes as well as chronic toxicity. For diseases such as lung 600 
cancer or airway remodelling driven by chronic inflammation, most studies have been 601 
done with mice or rats either in whole-body chambers (Heinrich et al., 1995) or in 602 
nose-only exposure towers (Pauluhn, 1994, 2008; Wong, 2007). For larger studies 603 
with many animal subjects, typical systems are either nose-only tower exposures with 604 
20 animals or more, or multiple whole-body cages exposed continuously to aerosols 605 
for up to several hours per day during periods ranging from days up to a year or two 606 
(Nikula et al., 1995). While the nose-only towers require a substantially larger work 607 
effort compared to the simpler whole body exposure chambers, the dosing precision is 608 
considerably better because exposure concentrations are more even, and because the 609 
animals are prevented from swallowing pelt-deposited material during grooming. 610 
Whole-body cages or nose-only exposures in towers are more suitable for chronic 611 
studies requiring a larger number of animals to reach statistical power but are only 612 
feasible when the test substance is available in sufficient amounts for production of 613 
the exposure atmosphere. 614 
Two common aerosol generator types to feed aerosol into such exposure 615 
systems are the Wright dust feeder and the jet mill generator (McClellan and 616 
Henderson, 1995), which both consume substantial amounts of test materials. 617 
However, the multiple-animal strategy is not optimal if only a limited amount of test 618 
substance is available, which is often the case with synthesized or collected air 619 
pollution materials (Oberdörster et al., 2005a; Seagrave et al., 2006). Moreover, 620 
during single animal exposures it is possible to control exposures of individual 621 
animals depending on their ventilation pattern and local aerosol concentration.  622 
So far instillation and insufflation methods have been most common for single 623 
animal exposures with limited amounts of test material. In the liquid instillation 624 
method, controlled volumes of dissolved or suspended materials are instilled into 625 
endotracheally intubated animals (Saffiotti et al., 1968; Warheit et al., 2007). The 626 
disadvantage of this method is an uneven distribution of poorly de-agglomerated 627 
materials in the lungs, quite different from ambient air exposures in experimental 628 
studies or in nature (Driscoll et al., 2000). 629 
The next step towards testing the toxicity of respirable aerosols is the direct 630 
insufflation method, where the study material is injected with an air puff directly into 631 
the endotracheally intubated lung, either as a liquid spray (Tronde et al., 2002) or as a 632 
suspended dry powder formulation (Bosquillon et al., 2004; Larsen and Regal, 2002). 633 
With some loss of dosing control, the distribution within the lung is improved, but it 634 
is still quite uneven with greater deposition in larger airways compared to more 635 
peripheral lung compartments (Bosquillon et al., 2004; Sakagami, 2006). For single-636 
animal rodent exposures to respirable aerosols fewer methods are available. With the 637 
modern piezoelectric nebulizers, rats can be exposed to respirable aerosols of 638 
dissolved or liquid-dispersed materials (MacLoughlin et al., 2009). 639 
While liquid suspensions can be used for drug delivery without too many 640 
problems, this may not be suitable for particulate air pollutants. Most air pollution 641 
particles of concern have chemically reactive sites on their surfaces that drive their 642 
toxicity. Many of these reactive sites are quenched by water or even humidity, which 643 
makes the liquid suspension both an unrealistic and unsuitable mode of administration 644 
(Seagrave et al., 2006). Instead, dry powder inhalation is preferred.  645 
For dry powder aerosols, the Dustgun technology offers one possibility to 646 
perform respirable aerosol exposures of single lungs that range in size from rodent 647 
lungs to dog lungs using small amounts of substance (Gerde et al., 2004; Gerde et al., 648 
2001). The Dustgun is a batch-wise operating generator using compressed air to 649 
suspend and deagglomerate dry powders into small volumes of respirable aerosols. 650 
The combination of the isolated, ventilated and perfused rat lung (IPL) and the 651 
Dustgun aerosol generator has been described elsewhere (Ewing et al., 2006; Selg et 652 
al., 2010). Recently, a novel active dosing system was combined with the Dustgun 653 
generator, where the measured aerosol concentration and the individual ventilation 654 
pattern of the exposed subjects were used to improve the dosing precision (Figure 8). 655 
This system can also be used for administering mineral dusts to either endotracheally 656 
intubated rodents or nose-only rodent setups. The advantage of exposing intubated 657 
instead of nose-only rodents is that substantial losses of exposure material depositing 658 
in the nasal airways can be avoided (Sakagami et al., 2003). The disadvantage is that 659 
anaesthesia is needed in experiments with tracheally intubated animals. 660 
7. Exhaled markers of airway inflammation during spaceflight 661 
7.1. Exhaled biomarkers 662 
Assessing lung health in extreme environments, such as space flight, demands 663 
non-invasive techniques. The analysis of biomarkers in the exhaled breath would meet 664 
such a requirement. Apart from the atmospheric and classical metabolic gases, the 665 
exhaled breath contains a number of other gases in trace amounts, including volatile 666 
organic compounds. Some of these compounds can be used to characterize the 667 
function of the whole organism (systemic biomarkers), and some are more 668 
specifically related to the function of the respiratory system (lung biomarkers). The 669 
analysis of breath condensates is an additional non-invasive technique in which breath 670 
condensate is collected by cooling or freezing exhaled gas (Kharitonov, 2004; 671 
Kharitonov and Barnes, 2001; Patil and Long, 2010; Popov, 2011).  672 
Examples on techniques and associated conditions are: 673 
• exhaled nitric oxide (NO) – airway inflammation (asthma, chronic obstructive 674 
pulmonary disease) 675 
• exhaled breath condensate – numerous markers of airway inflammation 676 
• exhaled hydrocarbons – oxidative stress  677 
Of these techniques only the analysis of exhaled nitric oxide is a standardized 678 
technique used in clinical practice. Breath condensate and hydrocarbons are both 679 
promising techniques but need further development. Additionally, new detection 680 
methods and improved analytical techniques of completely novel and potentially more 681 
precise markers of airway inflammation might be developed in the future. 682 
7.2. Exhaled nitric oxide (NO) 683 
The potential of NO as a marker of airway disease became apparent when 684 
Gustafsson et al. (1991) found endogenous NO in the exhalate from both animals and 685 
humans. In addition, Alving et al. (1993) and Persson et al. (1994) found increased 686 
levels of exhaled NO in asthmatics with ongoing airway inflammation. Normal 687 
exhaled NO levels are in the range of 10-35 parts per billion (ppb) in adults, and 688 
around 5-25 ppb in children (Taylor et al., 2006). For asthma patients not adequately 689 
treated with anti-inflammatory medication, exhaled NO levels are up to 70-100 ppb 690 
and sometimes even higher. Exhaled NO is now used as a diagnostic tool in the 691 
monitoring of asthma patients on Earth.  692 
Naturally occurring enzymatic processes produce NO from the amino acid L-693 
arginine and oxygen by the enzyme nitric oxide synthase (NOS). There are three 694 
different known isoforms of NOS; two constitutive and one inducible (iNOS). The 695 
constitutive NOS, i.e., neuronal NOS (nNOS) and endothelial NOS (eNOS), are 696 
strictly Ca2+-dependent, whereas iNOS is dependent on gene expression regulation.  697 
Potential sources of exhaled NO include the nasal epithelium (Lundberg et al., 698 
1995), the airway epithelium (Asano et al., 1994), the alveolar epithelium (Asano et 699 
al., 1994), the vascular endothelium (Ignarro et al., 1987), and the blood (Pawloski et 700 
al., 2001). NO enters the airway lumen by gas diffusion driven by a concentration 701 
gradient. All three isoforms of the NOS enzymes are present in the lung (Ricciardolo 702 
et al., 2004), but normal levels of exhaled NO match only the production quantity 703 
from iNOS activation (Ialenti et al., 1993; Lane et al., 2004).  704 
The NO turnover in the lungs is rapid, and part of the NO given off from 705 
tissues to the gas phase is exhaled. A similar or even larger quantity is taken up by the 706 
blood because NO binds very strongly to the haemoglobin in the blood. Thus, to fully 707 
understand the NO turnover in the lungs, the rate of “back diffusion” of NO from its 708 
site of formation in the airway wall to the lung alveoli must be assessed, as must the 709 
rate of NO transfer from the alveolar space to the blood.  710 
 711 
7.3. Effects of gravity and atmospheric pressure on exhaled NO 712 
The atmospheric pressure in future habitats on the Moon and Mars, and in 713 
vehicles made for interplanetary space missions, is likely to be substantially lower 714 
than that on Earth due to the desire to minimise decompression times prior to 715 
extravehicular activity. Studies have shown that normal healthy control values of 716 
exhaled NO are reduced in microgravity (Karlsson et al., 2009). Moreover, 717 
Hemmingson et al. ((2012)) have shown that pulmonary NO turnover is modified in 718 
reduced ambient pressure even though the exhaled NO partial pressure is not changed 719 
compared to normal ambient pressure. To establish normative values for exhaled NO 720 
in future spaceflight environments, the combined effects of gravity and cabin pressure 721 
on exhaled NO will need to be assessed.  722 
 723 
8. Pulmonary effects 724 
NASA’s effort to understand the pulmonary toxicity of lunar dust has been 725 
spearheaded by LADTAG. LADTAG has undertaken ground-based animal 726 
experiments based on the use of archived lunar soil (Apollo 14) that has been stored in 727 
NASA’s curation facility (http://www.lpi.usra.edu/captem/). The primary motivation 728 
for these experiments has been to derive a permissible exposure limit (PEL) for 729 
airborne lunar dust that is in the respirable size range, focusing on particles that are <3 730 
µm in diameter and for which exposure below the PEL is unlikely to cause health 731 
effects. The PEL will be used to set requirements for air quality for spacecraft and 732 
habitats that can be used in the design of future exploration missions to the Moon.  733 
For these studies (James, 2011; Rask et al., 2012) three different preparations 734 
of Apollo 14 lunar dust were used: lunar dust processed in a stainless steel jet mill to 735 
reduce particle size to < 3 μm; lunar dust processed by grinding in an oscillating ball 736 
mill, using a zirconium oxide grinding jar with zirconium oxide balls; and lunar dust 737 
that was not ground by any means, but was processed in a cyclone separator, to select 738 
for < 3 μm particles (James, 2011; Rask et al., 2012). Grinding of the Apollo 14 lunar 739 
dust specimens was necessary to generate adequate amounts of respirable size lunar 740 
dust needed for future rodent inhalation toxicity experiments planned by LADTAG 741 
(James, 2011). The three preparations of respirable lunar dust had comparable particle 742 
size, as determined by laser diffraction in an aqueous suspension (Rask et al., 2012). 743 
 744 
8.1. Intratracheal instillation studies 745 
In a series of experiments performed at the National Institute of Occupational 746 
Safety and Health (NIOSH, Morgantown, WV), LADTAG scientists carried out an 747 
intratracheal instillation study in rats, using the three Apollo 14 preparations described 748 
above, at doses of 1 mg, 2.5 mg and 7.5 mg per rat together with quartz (Min-U-Sil 5) 749 
and titanium dioxide as strong responder and low responder controls, respectively 750 
(Santana et al., 2010). Using bronchioalveolar lavage fluid cell counts, lactate 751 
dehydrogenase levels, albumin, and total protein as markers of inflammation, these 752 
experiments demonstrated that the inflammatory response in rats to lunar dust is 753 
intermediate between that of the titanium dioxide and quartz controls, at 7 days and at 754 
30 days post exposure. For these bronchioalveolar lavage fluid endpoints, the three 755 
different preparations of lunar dust were not distinguishable. Based on the findings of 756 
these lavage fluid studies, a preliminary permissible exposure limit of 1.0 mg/m3 (6 757 
months, intermittent exposure) was determined, using a benchmark dose analysis 758 
method (James, 2011). 759 
 760 
8.2. Differences in toxicity of dust due to method of lunar dust preparation – 761 
macrophage reactivity studies  762 
Freshly-fractured quartz is more toxic than aged quartz, and the leading 763 
explanation for this observation is the concept that mechanical disruption of quartz 764 
results in the homolytic and heterolytic  rupture of the silicon-oxygen bonds 765 
(“mechanochemical activation”) (Fubini and Hubbard, 2003). Increased surface 766 
radical content of the freshly-fractured material is well-correlated with enhanced 767 
toxicity. This finding is ascribed to the higher reactivity of dangling bonds and their 768 
potential to generate free radicals in aqueous solutions (Fubini, 1998; Fubini and 769 
Hubbard, 2003). Is a similar process important for lunar dust, which is exposed to 770 
continuous micrometeorite bombardment (Brunetto, 2009) (Figure 9)? The use of 771 
three different preparations of Apollo 14 lunar dust in the intratracheal instillation 772 
experiments performed by LADTAG provided a means of addressing this question 773 
(James, 2011). Indeed, the macrophage reactivity studies suggest that differences in 774 
chemical reactivity are in fact correlated with differences in biological response for 775 
lunar dust. 776 
Analysis of the three Apollo 14 lunar dust preparations revealed that the 777 
material prepared by grinding in a zirconium oxide ball mill exhibited 7-fold greater 778 
ability to generate hydroxyl radicals on addition to aqueous buffer, compared to jet-779 
mill processed material or un-ground (cyclone separation only) lunar dust, as judged 780 
by the terephthalate assay (Rask et al., 2012). One possible explanation for the 781 
observed increased ability to generate hydroxyl radicals in the ball-mill prepared 782 
material is an enhanced generation of dangling bonds compared to the other 783 
preparation methods. When a degranulation assay (luminol chemiluminescence) was 784 
used to analyze macrophages harvested via bronchioalveolar lavage in the LADTAG 785 
studies described above, increased macrophage reactivity was observed after exposure 786 
to the chemically reactive ball mill-prepared lunar dust, but not after exposure to the 787 
other two preparations where less or no mechanochemical activation is expected 788 
(Rask et al., 2012).  The macrophage reactivity assay used for these studies was the 789 
same as the assay used in studies of quartz that showed increased biological responses 790 
for freshly ground material versus aged (Porter et al., 2002). 791 
These findings support the concept that lunar dust toxicity is dependent on 792 
lunar dust chemical reactivity, and processes that cause mechanochemical activation 793 
contribute to this reactivity. Other processes that may cause increased lunar dust 794 
chemical reactivity, such as particle radiation exposure or UV light exposure, may be 795 
associated with enhanced toxicity as well (Figure 9). Additional ground-based 796 
experiments with lunar simulants, lunar dust, and its crystalline and amorphous phases 797 
might shed more light on the above findings. In situ measurement of the chemical 798 
reactivity of lunar dust, as it actually exists on the surface of the Moon, is likely the 799 
only way of assessing the net effects of multiple processes that may affect the 800 
chemical reactivity of lunar dust (Loftus et al., 2010).  801 
 802 
9. Knowledge gaps and recommendations  803 
 Tables 1 and 2 list the key knowledge gaps that exist for the physical and 804 
chemical properties of lunar dust (Table 1) and for its physiological and health effects 805 
(Table 2). It must be kept in mind that the samples of lunar material that were brought 806 
back from the Moon during the Apollo era were not optimized for studies of their dust 807 
component. Moreover, their chemical reactivity is unlikely to mirror that of lunar 808 
material in situ, since they have not been exposed to radiation and micrometeoroid 809 
impacts (Figure 9) for the last 40-50 years – nor have they been kept under vacuum.  810 
Previous work on the toxic effects of lunar material and simulants of lunar 811 
material in animal and cellular models has been made with the particles in aqueous 812 
media to avoid the large losses of precious material typical of conventional inhalation 813 
techniques. New techniques are now being developed which permit more economical 814 
inhalation studies in small animals. These techniques include individual and well-815 
controlled administration by nasal or intratracheal routes, the latter being the most 816 
exact and economical. Previous work on animal and cellular models has not addressed 817 
the effects of dust that has been “activated” with UV or proton radiation. Such studies 818 
should be given a high priority in the future. None of the curated lunar samples exist 819 
in a pristine state that preserves the surface reactive chemical aspects thought to be 820 
present on the lunar surface. Studies using this material therefore carry with them 821 
considerable uncertainty in terms of fidelity. As a consequence, in situ data on lunar 822 
dust properties are required for the ground-based studies to quantify the toxicity of 823 
dust exposure during future manned lunar missions. 824 
Based upon the knowledge gaps presented in Tables 1 and 2, we recommend a 825 
set of in situ measurements on the Moon, and a set of measurements in ground-based, 826 
analogue environments. The central goal of the in situ measurements is to gain 827 
sufficient understanding of the environment on the Moon, and of the physico-828 
chemical features and surface reactivity of lunar dust, so that the toxic effects of lunar 829 
dust can be mimicked and studied in ground-based experiments using both re-830 
activated material of lunar origin and lunar dust simulants.  831 
10. Summary 832 
Exposure of humans to lunar dust is likely to give rise to toxic reactions and 833 
should therefore be avoided, or at least minimized by undertaking a risk assessment 834 
and instigating appropriate measures to reduce exposure. Limits for permissible 835 
exposure must be based on scientific evidence, which is currently highly incomplete 836 
or absent. Dust toxicity is determined by the abundance, size distribution and 837 
chemical reactivity of dust particles. Chemical reactivity depends on the composition 838 
of dust in interaction with mechanical impacts from meteoroids and the exposure to 839 
proton and UV radiation in an environment free of oxygen and humidity. Currently 840 
used simulants of lunar dust and existing samples of actual lunar material are useful 841 
only for initial pilot experiments with cellular, animal and human experimental 842 
models of astronaut exposure to lunar dust. In situ determinations of factors such as 843 
abundance, size distribution and chemical reactivity of lunar dust particles are 844 
essential for a proper assessment of the risks for humans during future manned 845 
exploration of the Moon.   846 
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Figure captions 1298 
Figure 1. (a) Apollo 17 astronaut Gene Cernan covered in dust after extravehicular 1299 
activity on the lunar surface (photograph courtesy NASA). (b) Size distribution of n = 1300 
840 grains recovered from the spacesuit of Apollo 17 astronaut Harrison Schmitt, with 1301 
a mean of 10.7 μm. Modified from Christoffersen et al. (2009). 1302 
 1303 
Figure 2. Steps of cell and tissue interaction with nano and micron-sized particles in 1304 
the lung. When attained the alveolar space the particle may react with endogenous 1305 
molecules (step 1). The particle may then be cleared out of the lung either through the 1306 
mucociliary escalator (step 2) or through alveolar macrophage (AM) clearance (step 1307 
3). If reactive, AM activation will follow with release of several factors and 1308 
recruitment of other immune cells (AM and polymorphonucleate cells, PMN), 1309 
eventual cell death and establishment of permanent cycles of ingestion (step 4). This 1310 
process produces chronic inflammation (step 5). Combined with the direct action of 1311 
the particle (step 6) this will cause damage to the target cells (epithelial, endothelial).  1312 
If the particle is nano-sized, it may easily escape from the lung to the pleura and to 1313 
systemic circulation (step 7). 1314 
 1315 
Figure 3. The role of particle and cell derived free radicals and reactive oxygen 1316 
species (ROS) in cell damage, oxidative stress and diseases 1317 
 1318 
Figure 4. (a) Cumulative mass distribution of the grain size of selected Apollo soils, 1319 
modified from Liu and Taylor (2011). (b) Comparison between number distributions 1320 
of the grain size of the dust fraction of two Apollo samples and of the very fine 1321 
fraction of lunar dust simulant JSC-1Avf, modified from Park et al. (2008). 1322 
Figure 5. The effect of bond rupture following mechanical impact or cleavage in 1323 
crystalline silica, adapted from Fubini et al. (2001). This mechanism can be 1324 
extrapolated to silicates including lunar dust minerals and amorphous phases, 1325 
provided most of the chemical bonds are covalent.  1326 
 1327 
Figure 6. Total deposition of particles ranging in size from 0.5 to 3 μm in 1328 
microgravity (panel A), 1 G (panel B) and 1.6 G (panel C). In each case the bars to the 1329 
left of each pair (with error bars) are experimental data collected in humans. The bars 1330 
to the right are the predictions based on standard models of aerosol deposition and 1331 
include the effects of impaction (unshaded portion of the bar), sedimentation 1332 
(diagonal shading), and diffusion (black filled portion). Reproduced from Darquenne 1333 
et al. (1997) with permission. 1334 
 1335 
Figure 7. Deposition of inhaled aerosol in 1 G (upper line) and in lunar gravity (1/6 1336 
G) plotted as a function of volumetric depth in the airways to which the aerosol was 1337 
inhaled. A penetration volume of 300 ml indicates deposition in the small to medium 1338 
sized airways, while a penetration of volume of 1200 ml is within the alveoli. 1339 
Although deposition is reduced in lunar gravity compared to that in 1 G, a given 1340 
deposition fraction (say 25% as indicated by the dashed line) occurs much more 1341 
peripherally in reduced gravity. Redrawn from Darquenne et al. (2008) with 1342 
permission. 1343 
 1344 
Figure 8. A schematic drawing of the Dustgun system for the exposures of the 1345 
anaesthetised and tracheally intubated rat. PN, the pneumotachograph; DG, the 1346 
DustGun aerosol generator; MF, the end filter; V, the vacuum pump; totalV& , the 1347 
exposure airflow; ventV& , the ventilation airflow, generated by the spontaneously 1348 
breathing animal; filterV& , the constant component of the exposure airflow. The balance 1349 
of the airflow streams at the three-way junction is expressed as: 1350 
0=++ filterventtotal VVV &&& . 1351 
 1352 
Figure 9. UV light, particle radiation and mechanical disruption caused by 1353 
micrometeoroid bombardment, individually or in combination, may alter the surface 1354 
chemistry of lunar dust. Exposure to oxygen and water as well as other atmospheric 1355 
gases is expected to cause passivation of the chemical reactivity of lunar dust.     1356 
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Table 1. Knowledge gaps related to physical and chemical properties of dust in relation to potential toxicity 1380 
 
 
Number 
 
 
Topic 
Suspected 
relevance to 
dust toxicity 
Current state of 
knowledge for lunar 
dust 
Priority for 
lunar dust 
related 
measurements 
Type of studies required 
1 Activation of lunar dust due to proton radiation, 
galactic cosmic radiation, solar particle events, 
ultraviolet radiation, solar wind implantation, and 
micrometeoroid impact fragmentation 
High Unknown High Ground-based; 
In situ 
2 Identification and evaluation of surface-derived free 
radical generation pathways 
Very high Limited to some 
ground-based studies 
of lunar samples 
Critical Ground-based; 
In situ 
3 Passivation mechanism and rate after exposure of 
reactive lunar dust to habitat-like atmospheres 
High Unknown High Ground-based; 
In situ 
4 Size distribution, specific surface area of the 
submicron size fraction  
High Uncertain from 
measurements of 
lunar samples 
High Ground-based; 
In situ 
5 Size fraction variations of nanophase iron abundance Very high if 
it becomes 
exposed 
Abundance known for 
selected sites and size 
fractions 
High Ground-based; 
In situ 
6 Efficiency of release of nanophase iron from glassy 
matrix 
High if very 
efficient 
Limited High Ground-based 
 
7 Overall mineralogy High Well-known for 
limited number of 
sites, rough estimates 
available from remote 
sensing 
Medium In situ 
 
 
Number 
 
 
Topic 
Suspected 
relevance to 
dust toxicity 
Current state of 
knowledge for lunar 
dust 
Priority for 
lunar dust 
related 
measurements 
Type of studies required 
8 Other physical properties of the smallest size fraction 
(morphology, dielectric constant, crystallinity) 
Medium Poorly known Medium Ground-based; 
In situ 
9 Abundance of volatile components on the lunar 
surface 
Possibly high Significant 
uncertainties, 
particularly for high 
latitudes 
Unknown Ground-based on pristine 
Apollo samples; 
In situ 
10 Aerosol generation from lunar dust during typical 
mission activities 
High Medium from Apollo 
missions 
Medium In situ 
 1381 
Table 2: Knowledge gaps related to physiology and adverse health effects 1382 
 
 
Number 
 
 
Topic 
Suspected 
relevance to 
dust toxicity 
Current state of 
knowledge for lunar 
dust 
Priority for 
lunar dust 
related 
measurements 
Type of studies required 
11 Relation between surface active sites including those 
generated by radiation and micrometeoroid impact 
effects and adverse health effects 
Very high Unknown Critical Ground-based 
12 Toxicity of nanophase iron Very high Unknown High Ground-based 
13 Toxicity of ilmenite Low Unknown Low Ground-based 
14 Dust deposition in sustained low gravity  Medium Deposition in 
transient microgravity 
well-known (aircraft 
parabolic flights) 
Medium Low-gravity (ISS) 
15 Residence time of particles that deposit in the lung in 
lunar gravity  
High Currently under 
investigation 
High Parabolic flights 
16 Rate of mucociliary clearance of particles from the 
lung in lunar gravity 
High Unknown High Suborbital flight 
17 Effects of inhaled lunar dust on the cardiovascular 
system in disease models 
Low Unknown, based on 
air pollution research 
Low Ground-based 
18 Effects of inhaled lunar dust on the cardiovascular 
system in different gravitation environments. 
Low Unknown Low Ground-based 
19 Effects of inhaled lunar dust simulant in an animal 
model 
High Extrapolation from 
instillation of 
particles with an 
aqueous vehicle 
High Ground-based 
20 Effects of inhaled “activated” simulant (Proton, UV 
radiation) in an animal model 
High Unknown High Ground-based 
 
 
Number 
 
 
Topic 
Suspected 
relevance to 
dust toxicity 
Current state of 
knowledge for lunar 
dust 
Priority for 
lunar dust 
related 
measurements 
Type of studies required 
21 Effects of inhaled “activated” Apollo era lunar 
material 
High Unknown High Ground-based 
22 Time course of deactivation after irradiation of 
simulants and actual lunar material  
High Unknown High Ground-based 
23 Effects of combined microgravity and reduced 
pressure on the NO turnover in the lungs of humans 
High Partly known from 
micro-gravity and 
altitude separately 
High Low-gravity (ISS) 
24 Effects of dust-induced airway inflammation on 
exhaled markers other than NO 
High Unknown High Ground-based, animal 
and human experiments 
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